DR. CHEN
ActiveFinancials · financial year 2025, micro format
Annual accounts 2025 filed on 27-07-2026 at the NBB all 3 filings
2023 to 2025, 3 financial years
The operating result for 2025 is 14% lower than in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
Use the arrow keys on the chart for the figures per year.
Companies with the same profile, two years later
Historical observationIn July 2024, 39,278 companies had the same profile as DR. CHEN has now. Two years later, 1.8% had gone bankrupt and 95.9% were still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
The bankruptcy probability of DR. CHEN itself is lower: 0.3% within 12 months. It rests on far more data about DR. CHEN than the profile alone.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for DR. CHEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Gross operating margin9900 | €177,644 | €253,250 | €218,911 | ▼ 13.6% |
| Operating profit (loss)9901 | €177,644 | €253,250 | €218,911 | ▼ 13.6% |
| Financial income75/76B | €33 | €1,190 | €5,739 | ▲ 382% |
| Recurring financial income75 | €33 | €1,190 | €5,739 | ▲ 382% |
| Financial charges65/66B | - | €415 | €104 | ▼ 74.9% |
| Recurring financial charges65 | - | €415 | €104 | ▼ 74.9% |
| Profit (loss) for the period before taxes9903 | €177,677 | €254,025 | €224,545 | ▼ 11.6% |
| Income taxes67/77 | €39,953 | €59,558 | €52,967 | ▼ 11.1% |
| Profit (loss) for the period9904 | €137,724 | €194,468 | €171,578 | ▼ 11.8% |
| Profit (loss) for the period to be appropriated9905 | €137,724 | €194,468 | €171,578 | ▼ 11.8% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €146,373 | €395,125 | €258,116 | ▼ 34.7% |
| Current assets29/58 | €146,373 | €395,125 | €258,116 | ▼ 34.7% |
| Amounts receivable within one year40/41 | - | €40,927 | €42,376 | ▲ 3.5% |
| Other amounts receivable41 | - | €40,927 | €42,376 | ▲ 3.5% |
| Cash at bank and in hand54/58 | €146,373 | €353,845 | €215,386 | ▼ 39.1% |
| Deferred charges and accrued income490/1 | - | €352 | €355 | ▲ 0.8% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €146,373 | €395,125 | €258,116 | ▼ 34.7% |
| Equity10/15 | €138,724 | €333,192 | €202,769 | ▼ 39.1% |
| Contributions10/11 | €1,000 | €1,000 | €1,000 | = |
| Profit (loss) carried forward14 | €137,724 | €332,192 | €201,769 | ▼ 39.3% |
| Amounts payable17/49 | €7,649 | €61,933 | €55,347 | ▼ 10.6% |
| Amounts payable within one year42/48 | €7,649 | €61,933 | €55,347 | ▼ 10.6% |
| Trade debts44 | €3,702 | €2,375 | €2,380 | ▲ 0.2% |
| Suppliers440/4 | €3,702 | €2,375 | €2,380 | ▲ 0.2% |
| Taxes, remuneration and social security45 | €1,753 | €59,558 | €52,967 | ▼ 11.1% |
| Taxes450/3 | €1,753 | €59,558 | €52,967 | ▼ 11.1% |
| Other amounts payable47/48 | €2,195 | - | - | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €137,724 | €194,468 | €171,578 | ▼ 11.8% |
| Operating cash flow (approximation) | €137,724 | €194,468 | €171,578 | ▼ 11.8% |
| Change in cash | - | €207,472 | -€138,460 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.